Zentek (CVE:ZEN) Shares Up 10% – Still a Buy?

Zentek Ltd. (CVE:ZENGet Free Report) was up 10% on Friday . The company traded as high as C$1.60 and last traded at C$1.54. Approximately 81,255 shares were traded during mid-day trading, an increase of 223% from the average daily volume of 25,159 shares. The stock had previously closed at C$1.40.

Zentek Stock Up 20.7 %

The stock’s fifty day simple moving average is C$1.49 and its two-hundred day simple moving average is C$1.28. The company has a market capitalization of C$175.84 million, a price-to-earnings ratio of -14.08 and a beta of 0.77. The company has a debt-to-equity ratio of 5.91, a quick ratio of 7.59 and a current ratio of 2.20.

Zentek Company Profile

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.

Featured Articles

Receive News & Ratings for Zentek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zentek and related companies with MarketBeat.com's FREE daily email newsletter.